IP Verse

Tetraphase Pharmaceuticals, Inc. opposition analysis

COMPANY ANALYSIS

Patent Number:

Title:

Crystalline Eravacycline Bis-Hydrochloride

Applicant:

Opposition Date:

Jun 22, 2021

Patent:

Grant Date:

Oct 18, 2017

Title:

C7-Fluoro Substituted Tetracycline Compounds

Oppositions:

Patent Number	Title	Applicant	Opposition Date
EP3390358	Crystalline Eravacycline Bis-Hydrochloride	SANDOZ AG	Jun 22, 2021

Patent Number	Grant Date	Title	Total Oppositions
EP3000805	Oct 18, 2017	C7-Fluoro Substituted Tetracycline Compounds	1

SANDOZ AG

Feel free to send us a message here and we will get back to you